ÂÜÀòÂÒÂ×

Kevin Eggan is a prominent figure in the field of biology and pharmaceuticals, currently serving as the Chief Scientific Officer and Senior Vice President at BioMarin Pharmaceutical Inc. since October 2020, where responsibilities include overseeing discovery research and early development. As a founder of multiple companies, including EnClear Therapies, QurAlis, and Q-State Biosciences, Kevin has played a significant role in advancing biomedical research. Kevin's academic contributions include a long tenure as a Professor at Harvard University, where roles spanned from Assistant Professor to Principal Investigator at the Harvard Stem Cell Institute. Educational credentials include a PhD from the Massachusetts Institute of Technology and a Bachelor of Science from the University of Illinois Urbana-Champaign.